Active Ingredient: BENDAMUSTINE HYDROCHLORIDE
Proprietary Name: BENDAMUSTINE HYDROCHLORIDE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 100MG/4ML (25MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: N216078
Product Number: 001
Approval Date: Dec 15, 2022
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:
Prescription
Patent and Exclusivity Information
